Mucositis Versus Tumor Control: The Therapeutic Index of Adding Chemotherapy to Irradiation of Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1060-1063

  Lee, Irwin H ^a   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biologically equivalent dose; Concurrent chemotherapy; Mucositis; Therapeutic index

Indexed keywords

AVERAGE DIFFERENCE; CHEMORADIATION; CLINICAL TRIAL; CONCURRENT CHEMOTHERAPY; EQUIVALENT DOSE; HEAD-AND-NECK CANCER; MUCOSITIS; RANDOMIZED TRIAL; THERAPEUTIC INDEX; TUMOR BED; TUMOR CONTROL;

CHEMOTHERAPY; CONCURRENCY CONTROL; DIFFUSERS (OPTICAL); RADIATION; TUMORS;

RADIOTHERAPY;

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; MITOMYCIN C; RADIOSENSITIZING AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BIOEQUIVALENCE; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; DATA ANALYSIS; DOSIMETRY; HEAD AND NECK CANCER; HUMAN; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; THERAPY EFFECT; HEAD AND NECK TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RELATIVE BIOLOGIC EFFECTIVENESS;

COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; MUCOSITIS; RADIATION-SENSITIZING AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 68649088958     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.011     Document Type: Article

References (27)

1. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
2. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet 368 (2006) 843-854
3. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
4. Budach V., Stuschke M., Budach W., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 (2005) 1125-1135
5. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
6. Jeremic B., Shibamoto Y., Milicic B., et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18 (2000) 1458-1464
7. Semrau R., Mueller R.P., Stuetzer H., et al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: Updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1308-1316
8. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62 (1989) 679-694
9. Kasibhatla M., Kirkpatrick J.P., and Brizel D.M. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 1491-1495
10. Fowler JF: Correction to Kasibhatla, et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495). Int J Radiat Oncol Biol Phys 71 (2008) 326-329
11. Kaanders J.H., van der Kogel A.J., and Ang K.K. Altered fractionation: Limited by mucosal reactions?. Radiother Oncol 50 (1999) 247-260
12. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66 (2003) 253-262
13. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
14. Fowler J.F., Harari P.M., Leborgne F., et al. Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules. Radiother Oncol 69 (2003) 161-168
15. Dorr W., Hamilton C.S., Boyd T., et al. Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys 52 (2002) 911-917
16. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
17. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
18. Bentzen S.M., Ruifrok A.C., and Thames H.D. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother Oncol 38 (1996) 89-101
19. Bentzen S.M., and Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 25 (2007) 4096-4103
20. Browman G.P., Cripps C., Hodson D.I., et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12 (1994) 2648-2653
21. Haffty B.G., Son Y.H., Papac R., et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials. J Clin Oncol 15 (1997) 268-276
22. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
23. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
24. Olmi P., Crispino S., Fallai C., et al. Locoregionally advanced carcinoma of the oropharynx: Conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy-a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 78-92
25. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
26. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
27. Bensadoun R.J., Benezery K., Dassonville O., et al. French multicenter Phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys 64 (2006) 983-994